Home › NDC Lookup › RxCUI directory › RxCUI 310536

Glyburide 3 MG Oral Tablet — RxCUI 310536

RxNorm drug concept · Semantic clinical drug
RxCUI 310536 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310536
Official nameGlyburide 3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)484 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glyburide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps control blood sugar in adults with type 2 diabetes. It works alongside healthy eating and exercise, not in place of them.
  • Take it by mouth, usually with breakfast or your first main meal. Many people take it once a day, but some split it into two doses. Follow your prescriber's directions and the phar...
  • Low blood sugar. Skipping meals or not following your plan can bring it on. If you get confusion, seizures or pass out, that's an emergency and you need immediate care.
  • What is the biggest side effect to watch for?
📖 Read our full Glyburide guide →

🕸️ Concept Web — How Glyburide 3 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glyburide 3 MG Oral Tablet RxCUI 310536

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glyburide 4815
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Glynase 881404
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glyburide Oral Tablet 372333
    • Glyburide Oral Product 1156200
    • Glyburide Pill 1156201
    • Glyburide Oral Tablet [Glynase] 881406
    • Glynase Oral Product 1171933
    • Glynase Pill 1171934
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Glyburide 3 MG 315990
    • Glyburide 3 MG Oral Tablet [Glynase] 881409
    • Glyburide 3 MG [Glynase] 881408

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glyburide 3 MG SCDC · 315990
  • Glyburide Oral Tablet SCDF · 372333
  • Glyburide Oral Product SCDG · 1156200
  • Glyburide Pill SCDG · 1156201

Brand-Name Concepts

  • Glyburide 3 MG Oral Tablet [Glynase] SBD · 881409
  • Glyburide 3 MG [Glynase] SBDC · 881408
  • Glyburide Oral Tablet [Glynase] SBDF · 881406
  • Glynase Oral Product SBDG · 1171933
  • Glynase Pill SBDG · 1171934
  • Glynase BN · 881404

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 310536 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-8034-01 100 TABLET in 1 BOTTLE (0093-8034-01) Glyburide Teva Pharmaceuticals USA, Inc. 1999-05-11
00093-8035-01 100 TABLET in 1 BOTTLE (0093-8035-01) Glyburide Teva Pharmaceuticals USA, Inc. 1999-05-11
00093-8035-05 500 TABLET in 1 BOTTLE (0093-8035-05) Glyburide Teva Pharmaceuticals USA, Inc. 1999-05-11
00093-8036-01 100 TABLET in 1 BOTTLE (0093-8036-01) Glyburide Teva Pharmaceuticals USA, Inc. 1999-05-12
Observed labelers: Teva Pharmaceuticals USA, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.